Background: Evidence is mounting that the standard triple therapy against H. pylori infections has been losing clinical effectiveness, but triple therapy with levofloxacin, amoxicillin, and a proton pump inhibitor is effective and well tolerated.
Medellín, Colombia. Antecedentes: Hay una creciente evidencia de que la terapia triple estándar contra la infección por H. pylori viene perdiendo efectividad clínica.